Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy.
Shah N, Badheka AO, Grover PM, Patel NJ, Chothani A, Mehta K, Hoosien M, Singh V, Savani GT, Deshmukh A, Rathod A, Patel N, Panaich SS, Arora S, Schwartz C, Blisker M, Coffey JO, Mitrani RD, Fuster V, Viles-Gonzalez JF. Shah N, et al. Among authors: grover pm. Int J Cardiol. 2014 Jun 15;174(2):288-92. doi: 10.1016/j.ijcard.2014.04.011. Epub 2014 Apr 13. Int J Cardiol. 2014. PMID: 24794553
ST-T wave abnormality in lead aVR and reclassification of cardiovascular risk (from the National Health and Nutrition Examination Survey-III).
Badheka AO, Patel NJ, Grover PM, Shah N, Singh V, Deshmukh A, Mehta K, Chothani A, Hoosien M, Rathod A, Savani GT, Marzouka GR, Gupta S, Mitrani RD, Moscucci M, Cohen MG. Badheka AO, et al. Among authors: grover pm. Am J Cardiol. 2013 Sep 15;112(6):805-10. doi: 10.1016/j.amjcard.2013.04.058. Epub 2013 Jun 11. Am J Cardiol. 2013. PMID: 23764245
Presence of anti-viral and anti-parasitic antibodies and cardiovascular mortality: insights from NHANES III.
Grover PM, Badheka AO, Shah N, Patel NJ, Mehta K, Chothani A, Singh V, Savani GT, Deshmukh A, Rathod A, Patel N, Panaich SP, Arora S, Khalpada D, Bhalara V, Parmar NG, Mohamad T, Cohen MG. Grover PM, et al. Int J Cardiol. 2013 Oct 12;168(5):4826-30. doi: 10.1016/j.ijcard.2013.07.007. Epub 2013 Aug 5. Int J Cardiol. 2013. PMID: 23928344 No abstract available.
Non-influence of lipid lowering therapy in atrial fibrillation recurrence.
Mehta K, Grover PM, Shah N, Patel NJ, Chothani A, Singh V, Savani GT, Deshmukh A, Rathod A, Patel N, Panaich SS, Arora S, Nalluri N, Khalpada D, Bhalaria V, Parmar NG, Badheka AO, Viles-Gonzalez JF, Mitrani RD. Mehta K, et al. Among authors: grover pm. Int J Cardiol. 2013 Oct 12;168(5):5006-7. doi: 10.1016/j.ijcard.2013.07.119. Epub 2013 Aug 13. Int J Cardiol. 2013. PMID: 23953261 Clinical Trial. No abstract available.
Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.
Patel NJ, Hoosien M, Deshmukh A, Badheka AO, Grover PM, Shah N, Singh V, Mehta K, Chothani A, Savani GT, Arora S, Bhalara V, Patel N, Khalpada D, Rathod A, Vazzana TJ, Lafferty J, Viles-Gonzalez JF, Mitrani RD. Patel NJ, et al. Among authors: grover pm. Int J Cardiol. 2013 Nov 20;169(5):e84-6. doi: 10.1016/j.ijcard.2013.10.040. Int J Cardiol. 2013. PMID: 24377111 No abstract available.
Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy.
Badheka AO, Shah N, Grover PM, Patel NJ, Chothani A, Mehta K, Singh V, Deshmukh A, Savani GT, Rathod A, Panaich SS, Patel N, Arora S, Bhalara V, Coffey JO, Mitrani RD, Halperin JL, Viles-Gonzalez JF. Badheka AO, et al. Among authors: grover pm. Am J Cardiol. 2014 Apr 1;113(7):1159-65. doi: 10.1016/j.amjcard.2013.12.021. Epub 2014 Jan 14. Am J Cardiol. 2014. PMID: 24507168 Clinical Trial.
Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM Trial).
Badheka AO, Patel NJ, Grover PM, Shah N, Patel N, Singh V, Deshmukh AJ, Mehta K, Chothani A, Savani GT, Arora S, Rathod A, Marzouka GR, Lafferty J, Mehta JL, Mitrani RD. Badheka AO, et al. Among authors: grover pm. Am J Cardiol. 2014 Sep 1;114(5):727-36. doi: 10.1016/j.amjcard.2014.06.002. Epub 2014 Jun 18. Am J Cardiol. 2014. PMID: 25060415 Clinical Trial.
Predictors of J-point elevation in a cross sectional US cohort.
Badheka AO, Patel NJ, Singh V, Deshmukh A, Shah N, Grover P, Rathod A, Chothani A, Mehta K, Savani G, Myerburg RJ, Mitrani RD, Cohen MG. Badheka AO, et al. Int J Cardiol. 2013 Oct 3;168(3):3082-3. doi: 10.1016/j.ijcard.2013.04.085. Epub 2013 May 1. Int J Cardiol. 2013. PMID: 23642813 No abstract available.
Complication rates of atrial fibrillation ablations: comparison of safety outcomes from real world to contemporary randomized control trials.
Pothineni NV, Deshmukh A, Pant S, Patel NJ, Badheka A, Chothani A, Shah N, Mehta K, Savani GT, Singh V, Grover P, Bhalara V, Patel N, Arora S, Rathod A, Viles-Gonzalez J, Paydak H. Pothineni NV, et al. Int J Cardiol. 2014 Aug 1;175(2):372-3. doi: 10.1016/j.ijcard.2014.04.250. Epub 2014 May 2. Int J Cardiol. 2014. PMID: 24948560 Review. No abstract available.
Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.
Badheka AO, Chothani A, Mehta K, Patel NJ, Deshmukh A, Hoosien M, Shah N, Singh V, Grover P, Savani GT, Panaich SS, Rathod A, Patel N, Arora S, Bhalara V, Coffey JO, O'Neill W, Makkar R, Grines CL, Schreiber T, Di Biase L, Natale A, Viles-Gonzalez JF. Badheka AO, et al. Circ Arrhythm Electrophysiol. 2015 Feb;8(1):42-8. doi: 10.1161/CIRCEP.114.001413. Epub 2014 Dec 5. Circ Arrhythm Electrophysiol. 2015. PMID: 25480543
22 results